Fever Blister Cream 2g
Contains active ingredients including Acyclovir
Cipla Acitop Fever Blister Cream 2g
Composition: Each gram of cream contains 50 mg of acyclovir. (5.0 % w/w acyclovir). Preservative: Chlorocresol 0,12% m/m. Pharmacological classification: A 20.2.8. Antiviral agent. Pharmacological action: Acyclovir is an acyclic guanine nucleoside analogue that lacks the 3'-hydroxyl on the side chain. It is active against herpes simplex virus type 1 and 2. Acyclovir is phosphorylated intracellularly by viral thymidine kinase to the active triphosphate that inhibits viral DNA synthesis and replication by inhibiting the viral DNA polymerase enzymes. The active triphosphate is also incorporated into the herpes virus DNA. Normal cellular processes are not affected. Indications: Acitop is indicated for the symptomatic treatment of herpes simplex infections of the lips. Both the initial and recurrent infections can be successfully treated. Contra-indications: Hypersensitivity to acyclovir, propylglycol and chlorocresol. Identification: A white to off- white smooth cream. Presentation: Packed in pure aluminium collapsible tubes, containing 2 g, 5 g or 10 g of cream. © Cipla Life Sciences. Acitop. Cream/room. www.cipla.co.za. Customer care: 080 222 6662.
Quantity in pack:
A 20.2.8 antiviral agent. 2g. Acitop. Fever blister cream. Cipla.
How to use
Dosage and directions for use: Adults and children: Apply 5-6 times daily at four-hourly intervals. Therapy should be initiated as soon as possible following the onset of signs and symptoms of herpes simplex infection. This is particularly important in the treatment of recurrent episodes. Treatment should be continued for 5 days. If healing has not occurred, the treatment may be prolonged for up to 10 days. Cover all lesions adequately. Do not exceed the recommended dose. Use a finger cot or a rubber glove to prevent auto inoculation.
Store at or below 25 degrees C in a dry place.
Side-effects and special precautions: Transient stinging, burning or erythema may occur. Mild drying and flaking of the skin may occur with the application of Acitop. Avoid contact with the eyes. Acyclovir is intended for cutaneous use only. Safety in pregnancy has not been established. Resistance has been reported with varicella-zoster virus. Not recommended for application to mucous membranes. Known symptoms of overdosage and particulars of its treatment: See 'side effects' and 'special precautions'. Treatment is symptomatic and supportive if accidental ingestion has occurred. Acyclovir is dialysable. Keep out of reach of children.